BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 12, 2017
View Archived Issues
CFFT award supports Aridis' development of Panaecin for patients with cystic fibrosis
Read More
AMAG Pharmaceuticals enters licensing agreement with Palatin Technologies for bremelanotide
Read More
Aduro Biotech, Merck & Co. to investigate CRS-207 plus pembrolizumab in gastric cancer
Read More
ProNAi Therapeutics changes name to Sierra Oncology, transfers phase I trials of SRA-737
Read More
Phase I trial begins for Moderna's mRNA-based Zika vaccine candidate
Read More
DSMB recommends continuation of Evgen's phase II trial of SFX-01 in subarachnoid hemorrhage
Read More
IACTA acquires North American rights to Nanomerics' NM-133 for dry eye
Read More
Gemcabene shows efficacy for NASH in preclinical proof-of-concept study
Read More
LegoChem and Takeda enter research licensing agreement to evaluate next-generation ADC candidates
Read More
Abivax to receive funding to strengthen antiviral platform
Read More
G1 Therapeutics begins three breast cancer drug programs
Read More
Gilead's Vemlidy approved for HBV infection in E.U.
Read More
FDA grants orphan drug status to Sangamo Therapeutics' SB-318
Read More
Targeted knockdown of SMN-AS1 as a potential new SMA therapeutic strategy
Read More
FDA issues complete response letter for Tesaro's NDA for intravenous rolapitant
Read More
Genomics-based drug repurposing identifies sitagliptin as potential antiepileptic drug
Read More
FDA grants QIDP and fast track designations to VivaGel in bacterial vaginosis
Read More
RedHill Biopharma's RHB-104 awarded FDA QIDP designation
Read More
Gas6-AXL pathway as a new target for development of ZIKV therapies
Read More
Bird Rock Bio cleared to begin phase I study of namacizumab
Read More
Bayer patents anticancer compounds
Read More
Takeda reports M1 PAMs for Alzheimer's disease
Read More
Kissei Pharmaceutical describes TRPM8 antagonists
Read More
